NCT00944801 Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE1/PHASE2
NCT00943826 A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE3
NCT00941460 Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma Status COMPLETED Phase PHASE2
NCT00939991 Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas Status COMPLETED Phase PHASE1/PHASE2
NCT00921167 A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas Status COMPLETED Phase PHASE2
NCT00895960 Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma Status TERMINATED Phase PHASE1
NCT00884741 Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE3
NCT00864864 Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma Status COMPLETED Phase EARLY_PHASE1
NCT00846456 Safe Study of Dendritic Cell (DC) Based Therapy Targeting Tumor Stem Cells in Glioblastoma Status COMPLETED Phase PHASE1/PHASE2
NCT00821080 Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma Status COMPLETED Phase PHASE1
NCT00813943 Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status Status COMPLETED Phase PHASE2
NCT00807027 Clinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea Status COMPLETED Phase PHASE3
NCT00790452 Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma Status TERMINATED Phase PHASE2
NCT00762255 A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma Status COMPLETED Phase PHASE1
NCT00761280 Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma Status TERMINATED Phase PHASE3